Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling ...
What's Going On With Trinity Biotech Shares Tuesday?
Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...
Trinity Biotech faces US aid policy impact, PPP loan scrutiny
Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based diagnostic company with a market capitalization of $23.7 million and current trading price of $1.32, is evaluating the potential effects of a recent ...
StockNews.com Initiates Coverage on Trinity Biotech (NASDAQ:TRIB)
Analysts at StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the stock. Trinity ...
Trinity Biotech Shares Rise After Update on Next-Gen Blood-Sugar Monitoring Device
Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes ...